Skip to main content
. 2021 Jul 12;16(7):e0254118. doi: 10.1371/journal.pone.0254118

Table 1. Lipid screen design containing 31 different lipids or lipid mixtures.

Well Lipid Abbreviation Amount Comment References
A1 1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine DOPE 0.3 mg Phosphatidylethanolamine (PE) [43]
A2
A3
A4 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphoethanolamine POPE 0.3 mg Phosphatidylethanolamine (PE) [12]
A5
A6
A7 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine DPPE 0.3 mg Phosphatidylethanolamine (PE) [43]
A8
A9
A10 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine POPC 0.3 mg Phosphatidylcholine (PC) [44]
A11
A12
B1 1,2-Dioleoyl-sn-Glycero-3-Phosphocholine DOPC 0.3 mg Phosphatidylcholine (PC) [45]
B2
B3
B4 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine DMPC 0.3 mg Phosphatidylcholine (PC) [46]
B5
B6
B7 1,2-Dihexadecanoyl-sn-Glycero-3-Phosphocholine DPPC 0.3 mg Phosphatidylcholine (PC) [47]
B8
B9
B10 1-Myristoyl-2-Hydroxy-sn-Glycero-3-Phosphocholine LMPC 0.3 mg Phosphatidylcholine (PC) [48]
B11
B12
C1 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphoglycerol (sodium Salt) POPG-Na 0.3 mg Phosphoglyceride (PG) [49]
C2
C3
C4 1,2-Dipalmitoyl-sn-Glycero-3-Phospho-1’-rac-Glycerol (sodium salt) DPPG-Na 0.3 mg Phosphoglyceride (PG) [49]
C5
C6
C7 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phospho-L-Serine (sodium salt) POPS 0.3 mg Phosphatidylserine (PS) [50]
C8
C9
C10 1,2-Dioleoyl-sn-Glycero-3-Phospho-L-Serine (sodium salt) DOPS-Na 0.3 mg Phosphatidylserine (PS) -
C11
C12
D1 1,2-Didecanoyl-sn-Glycero-3-Phosphate (sodium salt) 10:PA-Na 0.3 mg Phosphatic acid (PA) [51]
D2
D3
D4 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphate (sodium salt) 16:0–18:1 PA (POPA) 0.3 mg Phosphatic acid (PA) -
D5
D6
D7 E. coli Polar Lipid Extract EPL 0.3 mg Mixture of PE (67%), PG (23.2%) and CA (9.8%) [52]
D8
D9
D10 Cholesteryl Hemisuccinate Tris Salt CHS 0.3 mg Sterol [53]
D11
D12
E1 Cholesterol CHL 0.3 mg Sterol [54]
E2
E3
E4 1’,3’-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol (sodium salt) 14:0 CL 0.3 mg Cardiolipin (CL) [13]
E5
E6
E7 1’,3’-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol (sodium salt) 18:1 CL 0.3 mg Cardiolipin (CL) [13]
E8
E9
E10 Porcine Polar Brain Lipid Extract PBL 0.3 mg Mixture of PC (12.6%), PE (33.1%), PI (4.1%), PS (18.5%), PA (0.8%) and unknown (30.9%) [55]
E11
E12
F1 Egg Sphingomyelin (chicken) SM 0.3 mg Mixture of sphingomyelins (SM) with 16:0 SM (86%), 18:0 SM (6%), 22:0 SM (3%), 24:1 SM (3%), unknown (2%) [56]
F2
F3
F4 Monomyristolein 7.7MAG 0.3 mg Monoacylglycerol [57]
F5
F6
F7 Monoolein 9.9MAG 0.3 mg Monoacylglycerol [58]
F8
F9
F10 Lipid mix I POPC:POPG: POPE (3:1:1)* 0.3 mg Used for structure solution of several ion channels [5961]
F11
F12
G1 Lipid mix II POPC:POPS (4:1)* 0.3 mg Simple mimic of the membrane inner lipid leaflet -
G2
G3
G4 Lipid mix III POPG:POPE (3:1)* 0.3 mg Simple mimic of Gram-positive bacterial membranes -
G5
G6
G7 Lipid mix IV POPG:POPE (1:3)* 0.3 mg Simple mimic of Gram-negative bacterial membranes -
G8
G9
G10 Lipid mix V DMPC:CHL (2:1)* 0.3 mg Simple mimic of eukaryotic plasma membranes -
G11
G12
H1 Lipid mix VI POPC:CHL (5:1)* 0.3 mg Simple mimic of nerve cell membranes -
H2
H3
H4 Lipid mix VII CHL:POPC:SM (1.8:1:1)* 0.3 mg Simple mimic of erythrocyte membranes -
H5
H6
H7 Lipid mix VIII POPC:POPE (1:1)* 0.3 mg Simple mimic of mitochondrial membranes -
H8
H9
H10 Blank Blank 0 mg Control -
H11
H12

* molar ratios.